Ajaykumar D. Rao, MD, MMSc, FACP, Chief of the Section of Endocrinology, Diabetes and Metabolism at the Lewis Katz School of Medicine at Temple University, provided perspective for an Everyday Health article on new research which suggests Black and Latinx people are less likely than white people to be prescribed glucagon-like peptide-1 receptor agonists (GLP-1s), which can greatly help with regulating blood sugar and managing chronic conditions such as type 2 diabetes and obesity, even though there’s a higher incidence of diabetes in those populations.
Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH